Get your Pfizer COVID-19 vaccine. Walk-ins welcome! Mon., Wed., Fri.: 8 a.m. - 5 p.m. and Tues., Thurs.: 8 a.m. - 7 p.m. >

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Investigator: Bincy Abraham, MD

Study Coordinator: Alejandro De La Torre

Status: Enrolling

ClinicalTrials.gov Number: NCT01848561

Phone: 713.441.6396

Protocol Number: Pro00011106

Description

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials